Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Flomax for Symptomatic Relief in BPH
NCT02244242Phase 4Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Jul 1998
- Primary completion
- Aug 1999
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of tamsulosin in benign prostatic hyperplasia (BPH), sponsored by Boehringer Ingelheim. Started Jul 1998; status: completed.
02
Drugs
tamsulosin
03
Conditions
benign prostatic hyperplasia (BPH)
Beyond the preview
Go deeper on NCT02244242.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02244242.